Genetics

This blog post examines how a large-scale Mendelian randomization analysis used genetic variants to investigate whether circulating metabolites may play causal roles in multiple sclerosis. The study evaluated 571 metabolites and prioritized 29 candidates linked to disease risk, including serine, lysine, acetone, acetoacetate, uridine, and lipids within specific VLDL and HDL subclasses. By integrating metabolomics with genome-wide association data, the research moves beyond observational correlations and highlights metabolic pathways that may contribute to multiple-sclerosis pathogenesis, while also identifying important targets for replication, mechanistic investigation, biomarker development, and future therapeutic research.